Published in Mol Microbiol on May 01, 2000
Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A (2003) 9.15
Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev (2003) 4.14
Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev (2005) 3.39
Tuberculosis: latency and reactivation. Infect Immun (2001) 3.15
Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog (2008) 3.02
A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci U S A (2003) 2.50
Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth. Proc Natl Acad Sci U S A (2002) 2.41
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol (2012) 2.40
Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med (2005) 2.10
Mycobacterium tuberculosis genes induced during infection of human macrophages. Infect Immun (2002) 2.04
Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci U S A (2007) 1.86
Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. J Clin Invest (2006) 1.66
Virulence factors of the Mycobacterium tuberculosis complex. Virulence (2012) 1.64
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs. PLoS Comput Biol (2005) 1.55
The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2007) 1.49
Cholesterol metabolism increases the metabolic pool of propionate in Mycobacterium tuberculosis. Biochemistry (2009) 1.45
Regulation of Mycobacterium tuberculosis cell envelope composition and virulence by intramembrane proteolysis. Nature (2005) 1.44
Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PLoS One (2007) 1.41
MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria. Chem Biol (2012) 1.40
Mycobacterium marinum Erp is a virulence determinant required for cell wall integrity and intracellular survival. Infect Immun (2006) 1.39
Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob Agents Chemother (2004) 1.34
Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis. Chem Biol (2009) 1.20
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis. Nat Chem Biol (2013) 1.20
A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 1.16
Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis. J Biol Chem (2010) 1.15
Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol (2005) 1.11
A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest (2011) 1.07
Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance. BMC Microbiol (2011) 1.06
Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis. MBio (2013) 1.03
Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow-derived macrophages for the control of Mycobacterium tuberculosis in vitro. Infect Immun (2006) 0.98
The Mycobacterium tuberculosis FAS-II dehydratases and methyltransferases define the specificity of the mycolic acid elongation complexes. PLoS One (2011) 0.98
Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect Immun (2004) 0.97
Loss of a mycobacterial gene encoding a reductase leads to an altered cell wall containing beta-oxo-mycolic acid analogs and accumulation of ketones. Chem Biol (2008) 0.95
Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system. FASEB J (2009) 0.95
X-ray structure of putative acyl-ACP desaturase DesA2 from Mycobacterium tuberculosis H37Rv. Protein Sci (2005) 0.93
Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice. Infect Immun (2012) 0.93
Comparative genomics of cell envelope components in mycobacteria. PLoS One (2011) 0.93
A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone. J Biol Chem (2012) 0.92
Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope lipids and pathogenesis. J Clin Invest (2006) 0.90
AccD6, a key carboxyltransferase essential for mycolic acid synthesis in Mycobacterium tuberculosis, is dispensable in a nonpathogenic strain. J Bacteriol (2011) 0.89
Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates. J Bacteriol (2010) 0.89
Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates. J Biol Chem (2010) 0.88
Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues. PLoS One (2013) 0.88
Physiology, Biochemistry, and Applications of F420- and Fo-Dependent Redox Reactions. Microbiol Mol Biol Rev (2016) 0.87
Drug-resistant tuberculosis can be predicted by Mycobacterial interspersed repetitive unit locus. Front Microbiol (2015) 0.87
Identification of a stress-induced factor of Corynebacterineae that is involved in the regulation of the outer membrane lipid composition. J Bacteriol (2009) 0.87
Structure of the sensor domain of Mycobacterium tuberculosis PknH receptor kinase reveals a conserved binding cleft. J Mol Biol (2012) 0.86
Identification of the Mycobacterium ulcerans protein MUL_3720 as a promising target for the development of a diagnostic test for Buruli ulcer. PLoS Negl Trop Dis (2015) 0.86
Rv0132c of Mycobacterium tuberculosis encodes a coenzyme F420-dependent hydroxymycolic acid dehydrogenase. PLoS One (2013) 0.86
Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth. PLoS One (2009) 0.85
Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis. BMC Microbiol (2003) 0.84
Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism. J Biol Chem (2012) 0.84
Differential effects of Mycobacterium bovis--derived polar and apolar lipid fractions on bovine innate immune cells. Vet Res (2012) 0.83
Pleiotropic effect of AccD5 and AccE5 depletion in acyl-coenzyme A carboxylase activity and in lipid biosynthesis in mycobacteria. PLoS One (2014) 0.82
Transcriptional regulation of fatty acid biosynthesis in mycobacteria. Mol Microbiol (2013) 0.82
Structure-function relationships of the antigenicity of mycolic acids in tuberculosis patients. Chem Phys Lipids (2010) 0.81
CpsA, a LytR-CpsA-Psr Family Protein in Mycobacterium marinum, Is Required for Cell Wall Integrity and Virulence. Infect Immun (2015) 0.81
New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics. Curr Pharm Des (2014) 0.81
S-adenosyl-N-decyl-aminoethyl, a potent bisubstrate inhibitor of mycobacterium tuberculosis mycolic acid methyltransferases. J Biol Chem (2009) 0.80
Lipidomics and genomics of Mycobacterium tuberculosis reveal lineage-specific trends in mycolic acid biosynthesis. Microbiologyopen (2014) 0.80
Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus. Mol Microbiol (2015) 0.80
The mycobacterial cell envelope-lipids. Cold Spring Harb Perspect Med (2014) 0.79
Transposon-5 mutagenesis transforms Corynebacterium matruchotii to synthesize novel hybrid fatty acids that functionally replace corynomycolic acid. Biochem J (2003) 0.79
Microarray analysis of the chelerythrine-induced transcriptome of Mycobacterium tuberculosis. Curr Microbiol (2010) 0.79
Possible association of GroES and antigen 85 proteins with heat resistance of Mycobacterium paratuberculosis. Appl Environ Microbiol (2004) 0.79
Lipid metabolism and Type VII secretion systems dominate the genome scale virulence profile of Mycobacterium tuberculosis in human dendritic cells. BMC Genomics (2015) 0.78
Modulation of transcriptional and inflammatory responses in murine macrophages by the Mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex. PLoS One (2011) 0.77
Revisiting the assignment of Rv0241c to fatty acid synthase type II of Mycobacterium tuberculosis. J Bacteriol (2010) 0.77
Differential Exoproteome analysis of two corynebacterium pseudotuberculosis biovar ovis strains isolated from goat (1002) and sheep (C231). Curr Microbiol (2013) 0.77
F420H2 Is Required for Phthiocerol Dimycocerosate Synthesis in Mycobacteria. J Bacteriol (2016) 0.76
M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model. PLoS One (2013) 0.76
Evolution of Mycolic Acid Biosynthesis Genes and Their Regulation during Starvation in Mycobacterium tuberculosis. J Bacteriol (2015) 0.76
An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition. Infect Immun (2014) 0.75
Mycolates of Mycobacterium tuberculosis modulate the flow of cholesterol for bacillary proliferation in murine macrophages. J Lipid Res (2017) 0.75
Effect of an Oxadiazoline and a Lignan on Mycolic Acid Biosynthesis and Ultrastructural Changes of Mycobacterium tuberculosis. Tuberc Res Treat (2011) 0.75
New synthetic lipid antigens for rapid serological diagnosis of tuberculosis. PLoS One (2017) 0.75
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Immunology of tuberculosis. Annu Rev Immunol (2001) 14.26
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65
Genetic mapping in Bacillus subtilis. J Mol Biol (1967) 7.61
Gene Ontology annotations and resources. Nucleic Acids Res (2012) 6.13
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Plastic mattresses and sudden infant death syndrome. Lancet (1995) 5.59
Stimulation of bone formation in vitro and in rodents by statins. Science (1999) 5.55
Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science (1993) 5.20
Gene conservation in Bacillus species. I. Conserved genetic and nucleic acid base sequence homologies. Proc Natl Acad Sci U S A (1965) 4.81
The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol (2001) 4.60
Ribosomal RNA synthesis and processing in a particulate site in the HeLa cell nucleus. Science (1966) 4.43
Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol Microbiol (1999) 4.27
Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron (2000) 4.17
Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol (1992) 4.04
Bacillus sporulation gene spo0H codes for sigma 30 (sigma H). J Bacteriol (1988) 3.88
Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science (1998) 3.83
Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J Biol Chem (2001) 3.76
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol (1998) 3.69
Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis (2001) 3.51
Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun (2000) 3.39
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Costs and benefits of cervical screening. I. The costs of the cervical screening programme. Cytopathology (1996) 3.25
Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science (1995) 3.25
Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med (2000) 3.20
Tuberculosis: latency and reactivation. Infect Immun (2001) 3.15
Chromosomal location of DNA base sequences complementary to transfer RNA and to 5 s, 16 s and 23 s ribosomal RNA in Bacillus subtilis. J Mol Biol (1968) 3.01
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun (2001) 2.94
Effects of aminoguanidine on latent murine tuberculosis. J Immunol (1998) 2.83
SinI modulates the activity of SinR, a developmental switch protein of Bacillus subtilis, by protein-protein interaction. Genes Dev (1993) 2.77
Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. Br Med J (Clin Res Ed) (1988) 2.65
Characterization of a cloned Bacillus subtilis gene that inhibits sporulation in multiple copies. J Bacteriol (1986) 2.59
Transformation and transduction in Bacillus subtilis: evidence for separate modes of recombinant formation. J Mol Biol (1969) 2.56
Bacillus subtilis early sporulation genes kinA, spo0F, and spo0A are transcribed by the RNA polymerase containing sigma H. J Bacteriol (1992) 2.50
A Bacillus subtilis regulatory gene product for genetic competence and sporulation resembles sensor protein members of the bacterial two-component signal-transduction systems. Genes Dev (1990) 2.44
Electromagnetically induced transparency and slow light with optomechanics. Nature (2011) 2.41
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J (2011) 2.36
Retracted Infectious measles virus from cloned cDNA. EMBO J (1990) 2.36
Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk--a review of the literature. Eur J Clin Nutr (2009) 2.35
The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages. Mol Microbiol (2001) 2.34
[Taxonomic value of mycobacterial fatty acids: proposal for a method of analysis]. Ann Microbiol (Paris) (1984) 2.27
Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun (1999) 2.26
Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J Bacteriol (1996) 2.19
Regulation of spo0H, a gene coding for the Bacillus subtilis sigma H factor. J Bacteriol (1991) 2.19
Electron microscopic studies of detergent-treated HeLa cell nuclei. J Mol Biol (1966) 2.19
Bacillus subtilis spo0H gene. J Bacteriol (1984) 2.18
The Arthritis and Rheumatism Council's National Repository of Family Material: pedigrees from the first 100 rheumatoid arthritis families containing affected sibling pairs. Br J Rheumatol (1994) 2.14
Assessment of pre-operative investigations of thyroglossal cysts. J R Coll Surg Edinb (1996) 2.13
Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology (1995) 2.11
Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J Clin Anesth (1995) 2.09
Pacifier use and sudden infant death syndrome: results from the CESDI/SUDI case control study. CESDI SUDI Research Team. Arch Dis Child (1999) 2.07
Spastic paraparesis after anaesthesia. Lancet (1999) 2.06
Gene conservation in Bacillus species. II. The location of genes concerned with the synthesis of ribosomal components and soluble RNA. Proc Natl Acad Sci U S A (1965) 2.04
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol (1999) 2.00
Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc Natl Acad Sci U S A (1999) 1.99
Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol (2011) 1.98
What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. Am J Respir Cell Mol Biol (2001) 1.98
Alcohol and driving: is the 0.05% blood alcohol concentration limit justified? Drug Alcohol Rev (1991) 1.98
Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM (2005) 1.97
Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A (2001) 1.96
Genetics and physiology of the rel system of Bacillus subtilis. Mol Gen Genet (1980) 1.95
Regulation of spo0H, an early sporulation gene in bacilli. J Bacteriol (1987) 1.94
Characterization of an iron-dependent regulatory protein (IdeR) of Mycobacterium tuberculosis as a functional homolog of the diphtheria toxin repressor (DtxR) from Corynebacterium diphtheriae. Infect Immun (1995) 1.92
MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J (1996) 1.92
Genetic mapping of antibiotic resistance in markers Bacillus subtilis. Proc Natl Acad Sci U S A (1970) 1.92
Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology (1995) 1.90
Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth (1997) 1.90
Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85
The Bacillus subtilis sin gene, a regulator of alternate developmental processes, codes for a DNA-binding protein. J Bacteriol (1991) 1.84
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
The Global TB Drug Facility: innovative global procurement. Int J Tuberc Lung Dis (2004) 1.81
Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register. Lancet (1987) 1.81
Sevoflurane versus desflurane for outpatient anesthesia: a comparison of maintenance and recovery profiles. Anesth Analg (1995) 1.80
Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J Gen Microbiol (1986) 1.79
Structure and expression of the Bacillus subtilis sin operon. J Bacteriol (1988) 1.79
InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology (2000) 1.77
Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infect Immun (2006) 1.74
The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun (2001) 1.73
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res (1992) 1.71
Neurological deterioration in young adults with phenylketonuria. Lancet (1990) 1.71
Models for tertiary structures. Myoglobin and lysozyme. J Chem Educ (1970) 1.70
Postoperative instructions: good compliance but is the advice sound? Anaesthesia (2001) 1.69
Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea. Cochrane Database Syst Rev (2004) 1.68
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. Ann Oncol (2008) 1.66
Separation of human tissue alkaline phosphatases by electrophoresis on acrylamide disc gels. Clin Chim Acta (1968) 1.66